These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28564533)

  • 1. From Accurate Assessment of Anti-HLA Antibody MFI to Complement-Binding Assays.
    Claisse G; Mariat C; Maillard N
    Clin Transpl; 2016; 32():153-160. PubMed ID: 28564533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison Between Total IgG, C1q, and C3d Single Antigen Bead Assays in Detecting Class I Complement-Binding Anti-HLA Antibodies.
    Moreno Gonzales MA; Mitema DG; Smith BH; Schinstock CA; Stegall MD; Wakefield LL; Henderson NA; DeGoey SR; Kreuter JD; Gandhi MJ
    Transplant Proc; 2017 Nov; 49(9):2031-2035. PubMed ID: 29149956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Mean Fluorescence Intensity and C1q/C3d-fixing capacities of anti-HLA antibodies.
    Claisse G; Absi L; Cognasse F; Alamartine E; Mariat C; Maillard N
    Hum Immunol; 2017 Apr; 78(4):336-341. PubMed ID: 28189573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting on target: Development of the novel, prozone-resistant, dual antibody rapid test (DART) for the LABScreen single antigen bead (SAB) assay.
    Greenshields A; Bray RA; Gebel HM; Liwski RS
    Hum Immunol; 2019 Jul; 80(7):468-477. PubMed ID: 31040048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical Limitations of the C1q Single-Antigen Bead Assay to Detect Complement Binding HLA-Specific Antibodies.
    Taylor CJ; Kosmoliaptsis V; Martin J; Knighton G; Mallon D; Bradley JA; Peacock S
    Transplantation; 2017 Jun; 101(6):1206-1214. PubMed ID: 27306532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ABCs (DRDQDPs) of the prozone effect in single antigen bead HLA antibody testing: Lessons from our highly sensitized patients.
    Greenshields AL; Liwski RS
    Hum Immunol; 2019 Jul; 80(7):478-486. PubMed ID: 31080010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EDTA Treatment for Overcoming the Prozone Effect and for Predicting C1q Binding in HLA Antibody Testing.
    Kim HS; Choi AR; Yang M; Oh EJ
    Ann Lab Med; 2019 Nov; 39(6):572-576. PubMed ID: 31240886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid-Phase C1q/C3d Fixing Readouts Correlate with High Median Fluorescence Intensity (MFI) De Novo Donor-Specific HLA Antibodies and C4d⁺ Antibody-Mediated Rejection in Kidney Transplant Recipients.
    Tatapudi VS; Kopchaliiska D; da Gente GJ; Buenaventura OF; Singh M; Laszik Z; Adey DB; Rajalingam R
    Ann Transplant; 2021 Dec; 26():e934175. PubMed ID: 34848674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays.
    Navas A; Molina J; Agüera ML; Guler I; Jurado A; Rodríguez-Benot A; Alonso C; Solana R
    Front Immunol; 2019; 10():1712. PubMed ID: 31428086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of C1q binding in the single antigen bead assay.
    Schaub S; Hönger G; Koller MT; Liwski R; Amico P
    Transplantation; 2014 Aug; 98(4):387-93. PubMed ID: 24918611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation.
    Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Transpl Int; 2017 Apr; 30(4):347-359. PubMed ID: 27717025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of complement binding assays to assess the efficacy of antibody mediated rejection therapy and prediction of graft survival in kidney transplantation.
    Ramon DS; Huang Y; Zhao L; Rendulic T; Park JM; Sung RS; Samaniego M
    Hum Immunol; 2017 Feb; 78(2):57-63. PubMed ID: 27894836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
    Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
    Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3d Assay in Correlation With Single Antigen Bead Assay for Human Leukocyte Antigen Antibodies.
    Ko SY; Lee W; Jung CW; Cho Y
    Transplant Proc; 2018 Oct; 50(8):2354-2358. PubMed ID: 30316357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Anti-HLA Antibodies of Highly Sensitized Patients by Single Antigen Bead and C1q Tests.
    Ayna TK; Koçyİğİt AÖ; Soypaçaci Z; Tuğmen C; Pirim I
    Transplant Proc; 2019 May; 51(4):1024-1026. PubMed ID: 31101164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
    Llorente S; Boix F; Eguia J; López M; Bosch A; Martinez H; Gonzalez MJ; López-Hernández R; Salgado G; Moya-Quiles MR; Campillo JA; García-Alonso AM; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Transplant Proc; 2012 Nov; 44(9):2535-7. PubMed ID: 23146446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?
    Böhmig GA; Kikic Z; Wahrmann M; Eskandary F; Aliabadi AZ; Zlabinger GJ; Regele H; Feucht HE
    Clin Biochem; 2016 Mar; 49(4-5):394-403. PubMed ID: 26118475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening Study.
    Eskandary F; Bond G; Kozakowski N; Regele H; Marinova L; Wahrmann M; Kikić Ž; Haslacher H; Rasoul-Rockenschaub S; Kaltenecker CC; König F; Hidalgo LG; Oberbauer R; Halloran PF; Böhmig GA
    Transplantation; 2017 Mar; 101(3):631-641. PubMed ID: 27120452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.
    Chen G; Sequeira F; Tyan DB
    Hum Immunol; 2011 Oct; 72(10):849-58. PubMed ID: 21791230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-Depth Analysis of Anti-HLA Antibodies Using C1q Assay.
    Zielińska H; Zieliński M; Dębska-Zielkowska J; Dukat-Mazurek A; Moszkowska G; Lewandowska D; Dębska-Ślizień A; Trzonkowski P
    Transplant Proc; 2022 May; 54(4):934-939. PubMed ID: 35534279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.